All the Swabs

Proove Biosciences has allegedly offered to pay doctors $30 for every patient they enrolled in a study of the company's genetic tests, while also pushing unnecessary testing, Stat News reports.

Proove says its genetic tests can predict how patients will respond to pain and other medication and even identify people who may be at risk of opioid addiction, though Stat News adds that many of the company's claims are supported by little science.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The London School of Economics' Daniele Fanelli argues at the Proceedings of the National Academy of Sciences that the reproducibility crisis in science isn't as dire as some say.

A team of researchers in Portugal has examined the genomic basis for racing pigeons' athleticism and navigational skills, finding it's likely polygenic.

Wired reports that diagnostic firms continue to seek, post-Theranos, the ability to diagnose diseases from small amounts of blood.

In Science this week: analysis of DNA from ancient North Africans, and more.